MiMedx Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	389.42	418.63	348.88	321.48	267.84	242.02
Revenue Growth (YoY)	10.51%	19.99%	8.52%	20.03%	10.67%	-2.50%
Cost of Revenue	73.82	73.01	60.07	54.63	48.32	39.63
Gross Profit	315.59	345.62	288.81	266.84	219.53	202.39
Selling, General & Admin	259.46	266.19	225.09	211.12	208.67	194.85
Depreciation & Amortization Expenses	0.64	0.44	0.77	0.76	0.7	0.82
Research & Development	15.91	15.1	12.34	12.67	12.7	9.93
Other Operating Expenses	-	-	-8.25	5.18	12.18	3.84
Total Operating Expenses	276.01	281.73	229.94	229.73	234.25	209.44
Operating Income	39.59	63.89	58.87	37.12	-14.73	-7.05
Total Non-Operating Income (Expense)	2.73	2.38	-1.57	-6.48	-5.02	-5
Pretax Income	42.32	66.26	57.29	30.63	-19.75	-12.05
Provision for Income Taxes	-11.62	-17.68	-15.3	36.81	-0.21	-0.25
Net Income	30.7	48.58	42.42	58.23	-30.2	-10.29
Earnings From Discontinued Operations	-	-	0.42	-9.21	-10.24	2.02
Net Income to Common	30.7	48.58	42.42	58.23	-30.2	-10.29
Net Income Growth	-23.60%	14.52%	-27.15%	-	-	-
Shares Outstanding (Basic)	148	148	147	116	113	110
Shares Outstanding (Diluted)	149	150	149	146	113	110
Shares Change (YoY)	0.25%	0.45%	2.11%	29.27%	2.32%	1.94%
EPS (Basic)	0.21	0.33	0.29	0.40	-0.33	-0.17
EPS (Diluted)	0.20	0.32	0.28	0.37	-0.33	-0.17
EPS Growth	-25.93%	14.29%	-24.32%	-	-	-
Shares Outstanding	148.93	148.09	146.93	146.23	113.71	111.93
Free Cash Flow	69.36	72.97	64.52	24.79	-19.41	-5.2
Free Cash Flow Growth	-4.95%	13.11%	160.27%	-	-	-
Free Cash Flow Per Share	0.46	0.49	0.43	0.17	-0.17	-0.05
Gross Margin	81.04%	82.56%	82.78%	83.01%	81.96%	83.63%
Operating Margin	10.17%	15.26%	16.87%	11.55%	-5.50%	-2.91%
Profit Margin	7.88%	11.60%	12.16%	18.11%	-11.27%	-4.25%
FCF Margin	17.81%	17.43%	18.49%	7.71%	-7.25%	-2.15%
EBITDA	52.88	78.77	64.91	40.54	-10.68	-1.87
EBITDA Margin	13.58%	18.82%	18.60%	12.61%	-3.99%	-0.77%
EBIT	39.59	63.89	58.87	37.12	-14.73	-7.05
EBIT Margin	10.17%	15.26%	16.87%	11.55%	-5.50%	-2.91%
Effective Tax Rate	-27.46%	-26.69%	-26.70%	120.15%	1.04%	2.05%

SEC Filings: 10-K · 10-Q